Rapid Micro Biosystems (RPID) Operating Expenses (2020 - 2026)

Rapid Micro Biosystems has disclosed Operating Expenses across 7 years of filings, most recently posting $14.2 million for Q1 2026.

• Operating Expenses for Q1 2026 came in at $14.2 million, up 17.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $76.3 million (up 8.82% YoY), and the FY2025 annual result was $81.0 million, up 3.86% from the prior year.
• Operating Expenses came in at $14.2 million for Q1 2026 at Rapid Micro Biosystems, down from $23.5 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $23.5 million in Q4 2025 to a low of $12.1 million in Q1 2025.
• The 5-year median for Operating Expenses is $19.6 million (2024), against an average of $19.2 million.
• Across the five-year window, Operating Expenses surged 30.46% in 2022 and plunged 39.32% in 2025, its largest moves.
• Rapid Micro Biosystems' Operating Expenses stood at $21.6 million in 2022, then dropped by 14.37% to $18.5 million in 2023, then retreated by 0.42% to $18.4 million in 2024, then advanced by 27.35% to $23.5 million in 2025, then plunged by 39.46% to $14.2 million in 2026.
• The last three Operating Expenses figures came in at $14.2 million (Q1 2026), $23.5 million (Q4 2025), and $19.2 million (Q3 2025), per Business Quant data.